Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ribociclib in the Treatment of Hormone-Receptor Positive/HER2-Negative Advanced and Early Breast Cancer: Overview of Clinical Data and Patients Selection.
Parati MC, Pedersini R, Perego G, Reduzzi R, Savio T, Cabiddu M, Borgonovo K, Ghilardi M, Luciani A, Petrelli F. Parati MC, et al. Among authors: cabiddu m. Breast Cancer (Dove Med Press). 2022 Apr 12;14:101-111. doi: 10.2147/BCTT.S341857. eCollection 2022. Breast Cancer (Dove Med Press). 2022. PMID: 35440873 Free PMC article. Review.
From the trastuzumab era to new target therapies: beyond revolution.
Barni S, Petrelli F, Cabiddu M, Cazzaniga ME, Cremonesi M. Barni S, et al. Among authors: cabiddu m. Ann Oncol. 2007 Jun;18 Suppl 6:vi1-4. doi: 10.1093/annonc/mdm214. Ann Oncol. 2007. PMID: 17591799 Free article. Review. No abstract available.
Toxicity of targeted therapies in elderly patients.
Barni S, Cabiddu M, Petrelli F. Barni S, et al. Among authors: cabiddu m. Expert Rev Anticancer Ther. 2008 Dec;8(12):1965-76. doi: 10.1586/14737140.8.12.1965. Expert Rev Anticancer Ther. 2008. PMID: 19046116 Review.
117 results